151 related articles for article (PubMed ID: 20385120)
1. Rationally designed chimeric peptide of met-enkephalin and FMRFa-[D-Ala2,p-Cl-Phe4]YFa induce multiple opioid receptors mediated antinociception and up-regulate their expression.
Vats ID; Chaudhary S; Sharma A; Nath M; Pasha S
Eur J Pharmacol; 2010 Jul; 638(1-3):54-60. PubMed ID: 20385120
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic intra-peritoneally administered chimeric peptide of met-enkephalin and FMRFa-[D-Ala2]YFa-on antinociception and opioid receptor regulation.
Vats ID; Snehlata ; Nath M; Pasha MA; Pasha S
Eur J Pain; 2010 Mar; 14(3):295.e1-9. PubMed ID: 19560378
[TBL] [Abstract][Full Text] [Related]
3. Hypotensive effect of novel chimeric peptides of met-enkephalin and FMRFa.
Hanif K; Fahim M; Pavar MC; Bansal V; Pasha S
Regul Pept; 2005 Feb; 125(1-3):155-61. PubMed ID: 15582727
[TBL] [Abstract][Full Text] [Related]
4. YFa, a chimeric opioid peptide, induces kappa-specific antinociception with no tolerance development during 6 days of chronic treatment.
Vats ID; Dolt KS; Kumar K; Karar J; Nath M; Mohan A; Pasha MA; Pasha S
J Neurosci Res; 2008 May; 86(7):1599-607. PubMed ID: 18183621
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, conformational and pharmacological studies of glycosylated chimeric peptides of Met-enkephalin and FMRFa.
Masand G; Hanif K; Sen S; Ahsan A; Maiti S; Pasha S
Brain Res Bull; 2006 Jan; 68(5):329-34. PubMed ID: 16377439
[TBL] [Abstract][Full Text] [Related]
6. Endogenous peptide: Met-enkephalin-Arg-Phe, differently regulate expression of opioid receptors on chronic treatment.
Vats ID; Chaudhary S; Karar J; Nath M; Pasha Q; Pasha S
Neuropeptides; 2009 Oct; 43(5):355-62. PubMed ID: 19716174
[TBL] [Abstract][Full Text] [Related]
7. Chimeric peptide of met-enkephalin and FMRFa: effect of chlorination on conformation and analgesia.
Hanif K; Gupta K; Gupta S; Gupta YK; Maiti S; Pasha S
Neurosci Lett; 2006 Jul; 403(1-2):131-5. PubMed ID: 16764989
[TBL] [Abstract][Full Text] [Related]
8. Antinociceptive activity of [beta-methyl-2', 6'-dimethyltyrosine(1)]-substituted cyclic [D-Pen(2), D-Pen(5)]Enkephalin and [D-Ala(2),Asp(4)]Deltorphin analogs.
Bilsky EJ; Qian X; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 2000 Apr; 293(1):151-8. PubMed ID: 10734164
[TBL] [Abstract][Full Text] [Related]
9. Effects of intracerebroventricularly administered chimeric peptide of metenkephalin and FMRFa--[D-Ala2]YFa-on antinociception and its modulation in mice.
Gupta S; Pasha S; Gupta YK; Bhardwaj DK
Brain Res Bull; 2001 May; 55(1):51-7. PubMed ID: 11427337
[TBL] [Abstract][Full Text] [Related]
10. Intracellular cAMP assay and Eu-GTP-γS binding studies of chimeric opioid peptide YFa.
Kumar K; Kumar S; Kurupati RK; Seth MK; Mohan A; Hussain ME; Pasha S
Eur J Pharmacol; 2011 Jan; 650(1):28-33. PubMed ID: 20887721
[TBL] [Abstract][Full Text] [Related]
11. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
Ward SJ; Takemori AE
J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
[TBL] [Abstract][Full Text] [Related]
12. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
13. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia.
Zhou L; Zhang Q; Stein C; Schäfer M
J Pharmacol Exp Ther; 1998 Aug; 286(2):1000-6. PubMed ID: 9694961
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
Machelska H; Labuz D; Przewłocki R; Przewłocka B
J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
16. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
17. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
Sterious SN; Walker EA
J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
[TBL] [Abstract][Full Text] [Related]
18. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
19. Lack of tolerance and morphine-induced cross-tolerance to the analgesia of chimeric peptide of Met-enkephalin and FMRFa.
Gupta K; Vats ID; Gupta YK; Saleem K; Pasha S
Peptides; 2008 Dec; 29(12):2266-75. PubMed ID: 18930087
[TBL] [Abstract][Full Text] [Related]
20. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
Cahill CM; White TD; Sawynok J
J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
